Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 11287
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
55663
Maybe Leo is looking to do a Deal for B-UC since
criscross99
04/29/2019 9:57:25 AM
55662
Here's a good article and illustrates how a
(3)
scgmck1
04/29/2019 9:55:44 AM
55660
Drano do you mean like BooDog repeatedly posting
criscross99
04/29/2019 9:40:21 AM
55659
Remember that picking food fights is a TOS
(2)
Drano
04/29/2019 9:37:13 AM
55658
20 days and
(1)
criscross99
04/29/2019 9:26:29 AM
55657
A deal could be inked any day. Licensing for B-OM
(2)
BooDog
04/29/2019 9:20:20 AM
55656
Then email it to Leo and see if it's pure BS.
criscross99
04/29/2019 9:05:09 AM
55655
Bingo!!!
bandg
04/29/2019 8:17:02 AM
55654
Im new to this board but from reading both of
(2)
Biobum99
04/29/2019 7:48:19 AM
55653
Pure bullish*t. Directly conflicts with every PR
Lemoncat
04/29/2019 7:34:12 AM
55652
You can only interpret his email one way. No BP
(2)
criscross99
04/28/2019 7:50:57 PM
55651
Please, everybody, use the Ignore feature. Last
(6)
petemantx
04/28/2019 7:43:19 PM
55650
It is really not important if the email is valid
(1)
Jimmyboy
04/28/2019 7:41:54 PM
55649
scgmck1 that will probably happen "most
(1)
criscross99
04/28/2019 7:23:56 PM
55648
Lcat Grow a pair and send my post to Leo. There
criscross99
04/28/2019 7:08:03 PM
55647
Wouldn't that be nice to see.
bandg
04/28/2019 6:57:55 PM
55646
The email circulating from Kelt proves you are
Lemoncat
04/28/2019 6:56:45 PM
55645
You two clowns are hilarious. You're both going
(3)
scgmck1
04/28/2019 6:39:46 PM
55644
Great.Send it to Leo. He'll tell you he sent it
criscross99
04/28/2019 1:15:45 PM
55643
Prison
Lemoncat
04/28/2019 12:27:50 PM
55642
lemoncat forward that email to Leo and his
criscross99
04/28/2019 9:43:55 AM
55641
I inputted 100k shares. I have yet to have
(2)
Biobum99
04/28/2019 3:08:03 AM
55640
Kelt doesnt have me fooled a bit. Hes been
(5)
Commando911
04/27/2019 8:31:51 PM
55639
Just the fact that he put from: Leo@ipharminc.com
Lemoncat
04/27/2019 8:03:07 PM
55638
How big was your trade? I haven't had an order
Lemoncat
04/27/2019 7:55:17 PM
55637
The reason for "no copyright" or confidentiality
(2)
Kelt
04/27/2019 7:06:29 PM
55636
per Finra .. they (NR/non retail) can do
(6)
4kids
04/27/2019 4:34:11 PM
55635
Thank you for your response. I placed an order
(1)
Biobum99
04/27/2019 4:11:39 PM
55634
input appreciated .. but as i've always explained
(8)
4kids
04/27/2019 3:26:48 PM
55633
You are incorrect. The copyright law has changed.
Drano
04/27/2019 1:45:22 PM
55632
Thanks for sharing Kelt. This is good news. Now
Lemoncat
04/27/2019 1:41:37 PM
55631
Here is the redacted version of Leo's email: In
(4)
Kelt
04/27/2019 1:35:22 PM
55630
There was NO copyright ,no nothing on his
criscross99
04/27/2019 1:22:46 PM
55629
It is improper to post an email from Mr. Ehrlich
(1)
Drano
04/27/2019 1:17:31 PM
55628
One could be new to any venue and still know
bandg
04/27/2019 1:17:07 PM
55627
See my post #55614 I have shared it with 7 of the
(3)
Kelt
04/27/2019 1:15:22 PM
55626
Terms of Service reminder: using epithets against
(1)
Drano
04/27/2019 1:14:40 PM
55625
That's freaking laughable Bandg. So being new to
criscross99
04/27/2019 1:03:14 PM
55624
Seems to me that Mr. Ehrlich, receiving an email
(1)
bandg
04/27/2019 12:59:35 PM
55623
Well then kelt has you fooled. I'm not giving my
(1)
criscross99
04/27/2019 12:57:28 PM
55622
I don't believe anything you say and I dismiss
bandg
04/27/2019 12:53:24 PM
55621
4kids, I have been a biotech investor for many
(2)
Biobum99
04/27/2019 12:33:42 PM
55619
Forward the email to lemoncat @ tutamail . com
Lemoncat
04/27/2019 12:26:53 PM
55618
Then post it sir. I think you are full of it! I'm
criscross99
04/27/2019 12:24:48 PM
55617
I'll put my hand on The Bible and swear that the
criscross99
04/27/2019 12:19:34 PM
55616
55604 "I'm disappointed he didn't correct your
bandg
04/27/2019 11:41:14 AM
55615
Sounds like you did commit fraud from what Kelt
Lemoncat
04/27/2019 11:11:36 AM
55614
As for my part,I do not plan to publicly share
(4)
Kelt
04/27/2019 11:05:18 AM
55613
yep .. their tou is both clever and basic
(7)
4kids
04/27/2019 10:40:16 AM
55612
Interesting: It was brought to my attention that
(5)
AlanC
04/27/2019 10:24:45 AM
Newer
Older
Recent Articles
Nxera Pharma Advances Immunotherapy Research in Cancer Clinical Trial
Western Forest Products Secures New US$30 Million Credit Facility
Western Forest Products Secures a New $30 Million Credit Facility
Discover the Growth Potential of Progressive Investments
Altimmune Investors Urged to Act Before Class Action Deadline
Revolutionizing Storytelling: Verily Storyworks Emerges
Breakthrough Results from ASC30 Study Unveiled at EASD Meeting
Navigating Opportunities in Recent Sable Offshore Corp. Lawsuit
Eisai's Etalanetug Tau Antibody Receives FDA Fast Track Status
Investors Stand United in LifeMD Securities Fraud Case
Exciting Developments in StubHub's Initial Public Offering
Brookfield Global Infrastructure Fund Declares Quarterly Dividend
Fly-E Group Faces Important Class Action Deadline for Investors
The Growth Journey of Dell Technologies Stock Over Five Years
Veteran Author Fosters Community Connections Through Book Event
Brookfield Announces Quarterly Distribution for Investors
Launched Investigation into Lesaka Technologies for Shareholders
Legal Guidance for CTO Realty Growth Investors Ahead of Deadline
A Remarkable Journey: The Growth of Starbucks Over 20 Years
Investors Have a Chance to Lead the Snap Inc. Lawsuit
Innovative Hair Care Solutions from Magic Sleek for All Types
Navigating Retirement: Rediscovering Purpose Beyond Work
How a $1000 Investment in OSI Systems Could Flourish
How $1000 in Cencora Became Over $6000 in Just 10 Years
Onyx Gold Secures $15 Million in Strategic Financing Deal
Investors Alert: Unicoin, Inc. Class Action Investigation
Honoring Ryan Silver: A Leader in College Basketball Impact
Leadership Changes at NanoXplore: A New Chapter Begins
SelectQuote's Legal Challenges: What Investors Should Know
G-P Recognized as a Pioneering Leader in EOR Solutions
KinderCare Faces Legal Challenges Amid Child Safety Allegations
Court's Ruling Protects Ontario's Water Supply from IEUA Deal
Celebrating Leadership Excellence: David M. Sullivan II's Impact
Celebrating Dr. Erica S. Becker: A Leading Oral Surgeon
How Supplier Onboarding Shapes Long-Term Business Relationships
Rosen Law Firm Urges Snap Inc. Investors to Take Action
aTyr Pharma's Share Turmoil: Investigating the Miscommunication
Turning Small Investments into Substantial Returns: F5's Journey
Exploring BlackRock's Transition of Mutual Funds to ETFs
How $100 in Lam Research Became a Remarkable Investment
LifeMD Faces Class Action Lawsuit Over Misleading Claims
Fair Trade Initiative Aims to Support U.S. Mushroom Farmers
Nutex Health Under Fire: Investor Lawsuit Over Financial Misconduct
Investor Concerns Rise Following Replimune's EUA Rejection
LanzaJet Applauds Transformative Investment in Sustainable Fuels
C3.ai Faces Class Action Claims Over Alleged Investor Misleading
Del Sol Food Company Celebrates Heritage with Premium Coffee
Understanding the Lantheus Holdings, Inc. Lawsuit for Investors
Heavy Industry Practices That Minimize Climate Impact on Equipment
Leadership Shift at NanoXplore: A New Era Begins